Differences
This shows you the differences between two versions of the page.
Next revision | Previous revisionBoth sides next revision | ||
b_cell [2022/09/29 17:38] pamela created | b_cell [2022/09/29 18:32] (current) pamela [SARS-CoV2 Antibody B Cells] | ||
---|---|---|---|
Line 17: | Line 17: | ||
Several distinct B-cell subsets have been defined that possess distinct functions in both adaptive and innate humoral immune responses. ((https:// | Several distinct B-cell subsets have been defined that possess distinct functions in both adaptive and innate humoral immune responses. ((https:// | ||
+ | |||
+ | ==== SARS-CoV2 Antibody B Cells ==== | ||
+ | |||
+ | Broad Institute - April 27, 2021 - By Sarah C.P. Williams | ||
+ | A study of antibody-producing B cells from patients who recovered from [[: | ||
+ | |||
+ | Inside the body of a person with COVID-19, the immune system’s B cells are engaged in a full-scale battle with the SARS-CoV-2 virus. But some B cells are better at this than others. Now, scientists from the Broad Institute of [[:MIT]] and [[: | ||
+ | |||
+ | The team studied blood samples from 14 people who recovered from COVID-19, and revealed distinct patterns of gene expression in B cells that produce antibodies that bind tightly to and neutralize SARS-CoV-2. They also discovered a **new antibody, BG10-19, which neutralizes the virus**, variants of concern such as ones first identified in the UK and South Africa, and the coronavirus that caused the 2003 SARS outbreak. | ||
+ | |||
+ | The findings, published today in Cell, could help scientists better understand why some people don’t respond as well to existing COVID-19 vaccines or therapies, a first step toward improving vaccines and treatments. ((https:// |